SEC Form D private-offering filing

Instylla, Inc.

Name: Instylla, Inc. - new SEC Form D private-offering filing, Bedford, MA
Published: 2025-10-23

A new SEC Form D private-offering notice from Bedford, MA, a $21,734,014 filer-stated offering target in Biotech. The source filing is one click away.

Instylla, Inc. site↗ Verified via SEC Form D

Medical device company developing resorbable liquid embolic agents for interventional radiology and oncology, maker of the FDA approved Embrace Hydrogel Embolic System.

Filed 2025-10-23Filed to raise $21,734,014First money in 2025-07-07Raised so far $21,734,014HQ (as filed) Bedford, MASector Biotech ✓Stage (inferred) EarlyCall status Late filing

Source linked the Form D on EDGAR↗Website verified instylla.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.